Clinical Trial Update: Dose Study of Tuberculin Purified Protein Derivative (JHP/Dose) [Phase 2]

View source ↗

Summary

This entry covers a Phase 2 dose study of Tuberculin Purified Protein Derivative (JHP/Dose) sponsored by JHP Pharmaceuticals LLC for tuberculosis infection.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tuberculosis Infection

Drugs mentioned

• Tuberculin Purified Protein Derivative (JHP/Dose) (Purified protein derivative (tuberculin))

Snippet

Sponsor: JHP Pharmaceuticals LLC | Conditions: Tuberculosis Infection | Phase 2 | Status: UNKNOWN